GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Symmetry Surgical Inc (FRA:RZV) » Definitions » Cyclically Adjusted Revenue per Share

Symmetry Surgical (FRA:RZV) Cyclically Adjusted Revenue per Share : €0.00 (As of Sep. 2014)


View and export this data going back to . Start your Free Trial

What is Symmetry Surgical Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Symmetry Surgical's adjusted revenue per share for the three months ended in Sep. 2014 was €2.007. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.00 for the trailing ten years ended in Sep. 2014.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-05-29), Symmetry Surgical's current stock price is €7.81. Symmetry Surgical's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2014 was €0.00. Symmetry Surgical's Cyclically Adjusted PS Ratio of today is .


Symmetry Surgical Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Symmetry Surgical's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Symmetry Surgical Cyclically Adjusted Revenue per Share Chart

Symmetry Surgical Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Symmetry Surgical Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Symmetry Surgical's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Symmetry Surgical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Symmetry Surgical's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Symmetry Surgical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Symmetry Surgical's Cyclically Adjusted PS Ratio falls into.



Symmetry Surgical Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Symmetry Surgical's adjusted Revenue per Share data for the three months ended in Sep. 2014 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2014 (Change)*Current CPI (Sep. 2014)
=2.007/100.4278*100.4278
=2.007

Current CPI (Sep. 2014) = 100.4278.

Symmetry Surgical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200412 1.840 80.290 2.302
200503 1.417 81.555 1.745
200506 1.675 82.062 2.050
200509 1.570 83.876 1.880
200512 1.406 83.032 1.701
200603 1.646 84.298 1.961
200606 1.454 85.606 1.706
200609 1.269 85.606 1.489
200612 1.223 85.142 1.443
200703 1.389 86.640 1.610
200706 1.469 87.906 1.678
200709 1.545 87.964 1.764
200712 1.570 88.616 1.779
200803 1.856 90.090 2.069
200806 1.998 92.320 2.173
200809 2.207 92.307 2.401
200812 2.085 88.697 2.361
200903 2.196 89.744 2.457
200906 2.029 91.003 2.239
200909 1.679 91.120 1.851
200912 1.471 91.111 1.621
201003 1.743 91.821 1.906
201006 2.029 91.962 2.216
201009 1.947 92.162 2.122
201012 2.025 92.474 2.199
201103 1.897 94.283 2.021
201106 1.827 95.235 1.927
201109 1.696 95.727 1.779
201112 1.780 95.213 1.877
201203 2.103 96.783 2.182
201206 2.245 96.819 2.329
201209 2.145 97.633 2.206
201212 2.219 96.871 2.300
201303 2.104 98.209 2.152
201306 2.037 98.518 2.076
201309 1.969 98.790 2.002
201312 2.198 98.326 2.245
201403 1.978 99.695 1.993
201406 2.037 100.560 2.034
201409 2.007 100.428 2.007

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Symmetry Surgical  (FRA:RZV) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Symmetry Surgical Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Symmetry Surgical's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Symmetry Surgical (FRA:RZV) Business Description

Traded in Other Exchanges
N/A
Address
Symmetry Medical, Inc., is a Delaware corporation incorporated on July 25, 1996. It is a source of medical device products. The Company provides medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry and other medical device markets. It also manufactures specialized non-healthcare products, mainly in the aerospace industry. It operates in two reportable segments namely Original Equipment Manufacturer (OEM) Solutions and Symmetry Surgical. Its main products produced in the OEM Solutions segment include: implants, including forged, cast and machined products for the global orthopedic device market; instruments used in the placement and removal of orthopedic implants and in other surgical procedures; cases, including plastic, metal and hybrid cases used to organize, secure and transport medical devices for orthopedic, endoscopy, dental and other surgical procedures; and other specialized products for the aerospace market. Symmetry Surgical is its new business segment. It arose from the integration of the Codman and Olsen Medical lines of surgical instruments with its Company's already existing hospital direct business, Specialty Surgical Instrumentation (SSI). Symmetry Surgical, which is headquartered in Nashville, Tennessee offers reusable stainless steel and titanium surgical hand-held instruments and retractor systems, sterile disposable surgical products, and sterilization containers. These products are used in the surgical specialties of spine, general/obstetrics/gynecology, microsurgery/neurosurgery, orthopedics, and laparoscopy, cardiovascular, thoracic and general surgery in the hospital setting as well as surgery centers and in select physician offices. The Company's OEM Solutions segment has manufacturing facilities in the U.S., United Kingdom, France, Ireland and Malaysia. The Company's subject to federal, state and local environmental laws and regulations governing the emission, discharge, use, storage and disposal of hazardous materials and the remediation of contamination associated with the release of these materials at our facilities and at off-site disposal locations.

Symmetry Surgical (FRA:RZV) Headlines